MedPath

Oral Nutritional Supplementation in Children at Risk of Undernutrition

Not Applicable
Completed
Conditions
Undernutrition
Interventions
Other: Dietary counseling
Other: Oral Nutritional Supplement
Registration Number
NCT05161000
Lead Sponsor
Abbott Nutrition
Brief Summary

The objective of this randomized, controlled trial is to evaluate the effects of consuming a pediatric oral nutritional supplement (ONS) plus dietary counseling for 120 days on anthropometric growth, strength, and nutritional status, compared with dietary counseling alone in undernourished children in the United States.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
279
Inclusion Criteria
  • Child is 36 months - 107 months of age.
  • Child is undernourished as determined by BMI for age z-score or Mid-upper-arm circumference z-score
  • Child's caregiver has voluntarily signed and dated an informed consent form (ICF), approved by an IRB, and provided Health Insurance Portability and Accountability Act (HIPAA) or other applicable privacy regulation authorization prior to any participation in the study.
  • Child's caregiver is willing to abstain from providing non-study oral nutrition supplements during the study period duration.
  • Child's caregiver is able and willing to follow study procedures and record data in parent diaries and complete any forms or assessments needed during the study.
  • Child is willing to consume the study product for the duration of the study, if randomized to intervention group
Exclusion Criteria
  • Child has a height-for-age z-score โ‰ฅ 0.

  • Child is currently drinking an oral nutritional supplement (ONS) on a regular basis (โ‰ฅ 15 days in the past month)

  • Child is participating in another study that has not been approved as a concomitant study by AN.

  • Child has been diagnosed with the following:

    • Galactosemia, or an allergy or intolerance to any ingredient found in the study product
    • Acute or chronic infections including but not restricted to respiratory infections, diarrhea, Hepatitis B or C, HIV infection or tuberculosis
    • Severe gastrointestinal disorders such as celiac disease, short bowel syndrome, pancreatic insufficiency, or cystic fibrosis
    • Neoplastic, renal, hepatic or cardiovascular, hormonal or metabolic disorders, Down's syndrome or significant, uncorrected cardiac anomalies that may impact growth
    • Infantile anorexia nervosa, developmental disability, including physical disorders such as cerebral palsy, or a developmental delay that is considered too severe for participation
    • Disorders of hemoglobin structure, function or synthesis
    • Clinically significant nutritional deficiency requiring specialty nutritional therapy
    • Any other clinically significant medical condition, which in the investigator's opinion, makes him or her unsuitable for inclusion in the study.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Control GroupDietary counselingdietary counseling
Oral Nutritional Supplement (ONS) GroupOral Nutritional SupplementTwo servings per day in addition to dietary counseling
Oral Nutritional Supplement (ONS) GroupDietary counselingTwo servings per day in addition to dietary counseling
Primary Outcome Measures
NameTimeMethod
Weight-for-age z-score (WAZ)baseline to 120 days

Change in weight-for-age z-score

Secondary Outcome Measures
NameTimeMethod
Appetitebaseline to 120 days

Visual analog scale from Ate Very Little to Ate A Lot

Mid-upper-arm circumference (MUAC)baseline to 120 days

Measured in cm

Heightbaseline to 120 days

Measured in cm

Dietary Diversitybaseline to 120 days

Measured by 24-hour dietary recall

Anthropometric Measurement Calculationsbaseline to 120 days

Standard z-scores and percentiles including weight-for-age, height-for-age, weight-for-height, BMI-for-age and mid-upper-arm-circumference-for-age

Weightbaseline to 120 days

Measured in Kg

Trial Locations

Locations (17)

Javara, Inc. 3377

๐Ÿ‡บ๐Ÿ‡ธ

Dallas, Texas, United States

L.A. Universal Research Center, Inc.

๐Ÿ‡บ๐Ÿ‡ธ

Los Angeles, California, United States

Springs Medical Research

๐Ÿ‡บ๐Ÿ‡ธ

Owensboro, Kentucky, United States

Dade Research Center, LLC

๐Ÿ‡บ๐Ÿ‡ธ

Miami, Florida, United States

D&H National Research Centers

๐Ÿ‡บ๐Ÿ‡ธ

Miami, Florida, United States

Suncoast Research, Assoc., LLC

๐Ÿ‡บ๐Ÿ‡ธ

Miami, Florida, United States

Midway Medical Clinic

๐Ÿ‡บ๐Ÿ‡ธ

Oneonta, Alabama, United States

HealthStar Research Glenwood

๐Ÿ‡บ๐Ÿ‡ธ

Glenwood, Arkansas, United States

HealthStar Research, LLC

๐Ÿ‡บ๐Ÿ‡ธ

Hot Springs, Arkansas, United States

Kissimmee Clinical Research

๐Ÿ‡บ๐Ÿ‡ธ

Kissimmee, Florida, United States

Velocity Clinical Research

๐Ÿ‡บ๐Ÿ‡ธ

Covington, Louisiana, United States

Southern Clinical Research

๐Ÿ‡บ๐Ÿ‡ธ

Zachary, Louisiana, United States

Alivation Research (Primary Care)

๐Ÿ‡บ๐Ÿ‡ธ

Lincoln, Nebraska, United States

Tribe Clinical Research LLC.

๐Ÿ‡บ๐Ÿ‡ธ

Greenville, South Carolina, United States

Javara Inc. 3380

๐Ÿ‡บ๐Ÿ‡ธ

Winston-Salem, North Carolina, United States

Proactive Clinical Research

๐Ÿ‡บ๐Ÿ‡ธ

Edinburg, Texas, United States

Gentle Pediatrics

๐Ÿ‡บ๐Ÿ‡ธ

Sugar Land, Texas, United States

ยฉ Copyright 2025. All Rights Reserved by MedPath